Kingdom Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25K Sell
39
-23
-37% -$1.32K ﹤0.01% 630
2026
Q1
$3.73K Buy
62
+22
+55% +$1.28K ﹤0.01% 601
2025
Q4
$2.16K Buy
+40
New +$1.92K ﹤0.01% 577

Other funds holding BMY

Kingdom Financial Group's BMY Position: Q2 2026 in Review

Kingdom Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 37% in Q2 2026, selling an estimated $1.32K and leaving 39 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

Kingdom Financial Group first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.73K in Q1 2026. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Kingdom Financial Group held 39 shares of Bristol-Myers Squibb worth $2.25K as of Q2 2026.
  • Kingdom Financial Group sold 23 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.32K.
  • Bristol-Myers Squibb made up ﹤0.01% of Kingdom Financial Group's portfolio in Q2 2026, its #630 holding.
  • Kingdom Financial Group first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Kingdom Financial Group's Bristol-Myers Squibb position peaked at $3.73K in Q1 2026.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Kingdom Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.